Log In
Print this Print this

Anti-IL-20 (NN8226)

Also known as: formerly Anti-IL20

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionRecombinant human mAb neutralizing IL-20
Molecular Target Interleukin-20 (IL-20)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today